---
category: news
title: "Wysa Receives FDA Breakthrough Device Designation for AI-led Mental Health Conversational Agent"
excerpt: "Wysa, a leading artificial intelligence (AI) based digital companion for behavioral health, has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its AI-based digital mental health conversational agent for patients 18 years and older with a diagnosis of chronic musculoskeletal pain (defined as pain lasting longer than three months) and depression and anxiety."
publishedDateTime: 2022-05-12T13:55:00Z
originalUrl: "https://www.tmcnet.com/usubmit/-wysa-receives-fda-breakthrough-device-designation-ai-led-/2022/05/12/9600762.htm"
webUrl: "https://www.tmcnet.com/usubmit/-wysa-receives-fda-breakthrough-device-designation-ai-led-/2022/05/12/9600762.htm"
type: article
quality: 7
heat: -1
published: false

provider:
  name: TMCnet
  domain: tmcnet.com

topics:
  - AI in Healthcare
  - AI

related:
  - title: "Wysa receives USFDA approval for AI led device for mental health"
    excerpt: "The device delivers cognitive behavioural therapy (CBT) via a smartphone-based conversational agent to reduce the symptoms of depression and anxiety, .."
    publishedDateTime: 2022-05-16T08:15:00Z
    webUrl: "https://health.economictimes.indiatimes.com/news/health-it/wysa-receives-usfda-approval-for-ai-led-device-for-mental-health/91592319"
    ampWebUrl: "https://health.economictimes.indiatimes.com/amp/news/health-it/wysa-receives-usfda-approval-for-ai-led-device-for-mental-health/91592319"
    cdnAmpWebUrl: "https://health-economictimes-indiatimes-com.cdn.ampproject.org/c/s/health.economictimes.indiatimes.com/amp/news/health-it/wysa-receives-usfda-approval-for-ai-led-device-for-mental-health/91592319"
    type: article
    provider:
      name: India Times
      domain: indiatimes.com
    quality: 59
    images:
      - url: "https://etimg.etb2bimg.com/thumb/msid-91592319,imgsize-18776,width-1200,height-628,overlay-ethealthworld/wysa-receives-usfda-approval-for-ai-led-device-for-mental-health.jpg"
        width: 1200
        height: 628
        isCached: true
  - title: "FDA grants breakthrough device designation for Wysa digital therapy"
    excerpt: "Wysa Ltd.â€™s artificial intelligence-based digital therapy received FDA breakthrough device designation for adults with chronic musculoskeletal pain, depression and anxiety. The device delivers cognitive behavioral therapy (CBT) via a digital companion or ..."
    publishedDateTime: 2022-05-12T22:28:00Z
    webUrl: "https://www.bioworld.com/articles/518747-fda-grants-breakthrough-device-designation-for-wysa-digital-therapy"
    type: article
    provider:
      name: BioWorld
      domain: bioworld.com
    quality: 39
    images:
      - url: "https://www.bioworld.com/ext/resources/BMT-source/2022/05-12-Wysa-featured.png?height=635&t=1652390572&width=1200"
        width: 847
        height: 635
        isCached: true
  - title: "FDA designates AI-based therapy for pain, depression, anxiety as breakthrough device"
    excerpt: "Wysa announced it has received breakthrough device designation from the FDA for its artificial intelligence-based digital mental health conversational agent for adults with chronic musculoskeletal pain,"
    publishedDateTime: 2022-05-13T19:24:00Z
    webUrl: "https://www.healio.com/news/psychiatry/20220513/fda-designates-aibased-therapy-for-pain-depression-anxiety-as-breakthrough-device"
    type: article
    provider:
      name: Healio
      domain: healio.com
    quality: 27

secured: "FG9BmT9W6rQLfc1zv6bt8Jv6PCESnlPVGTJXZcA707ZGGYu4L3gHCEpfVc6TtP8A9wBwiO4YbkPOW+TBij3AVORhpe3FIwENUKoR/oVhLQqhhLgFmQUUOumrk4xYyMJMrms/HfbBxwaWEES8Q89GEu++ozg5SOsFoY6VDlaGfLTj5C8VUBeYfw6PdJRnhjID7waNrmLg7ZSyfjsvsmwtm6GP27FThkvG0LF6BT/9VFGYWESfkG87ExARVtLlTSCIbBy2kfkgGbuq1Dqe9Fr8wFuOr+49ij2Yml/dPpJvA74nOpLKxIcW3jVw+qGfgz/GagC/V9RdMVpDdhfgWnUoDZJI2SDv6Ci/shZ8T17Qhc8=;QBiGNKmaPGIkOZ8rJDNtQg=="
---

